Li, Q., Liu, M., Ma, F., Luo, Y., Cai, R.G., Wang, L.M., Xu, N.Z. and Xu, B.H. (2014) Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal Asubtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel. PLoS ONE, 9, e104870.